Unsupported browser

You are using an outdated browser. Please upgrade your browser to improve your experience.

Sign up for an Award

Participate with your entry in one of our professional or student awards.

Sign up for an award

Sign up for a Profile

Create your own profile and publish it in the iF WORLD DESIGN GUIDE.

Sign up for a profile

Learn more:

iF SOCIAL IMPACT PRIZE

Present your project for free and win your share of EUR 50,000 in prize money.

Publish your project

Facilitate access to crucial medicines / Biosimilar solutions to health issues

The expiration of the patents and/or data protection for the first major group of originator’s biotherapeutic products (such as insulin). This is expected to contribute to increased access to these products at an affordable price. Worldwide, the development of biosimilars has contributed to reduce the cost of medicines by up to 50%. ICGEB’s objective is to increase access to medicines through fostering internal domestic production capacity in the field of biopharmaceuticals. Our aim is to contribute to achieving the targets set by the UN SDS's and in particular to achieving universal health coverage and reduce inequalities.

Client / Manufacturer

ICGEB

ICGEB
Trieste, Italy

Design

ICGEB Cape Town

ICGEB Cape Town
Cape Town, South Africa

Design

ICGEB New Delhi

ICGEB New Delhi
New Delhi, India